The Eastern Star has given $341,654 in gifts since it designated OMRF as its charitable beneficiary in 2002.
In 1968, doctors told Greg Kindell that he had acute myeloid leukemia and he had just six weeks to live. Now he’s been cancer-free for 50 years.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
OMRF researchers have broken new ground in understanding how the lymphatic system works.
Over the past 43 years, Putnam City students, teachers and families have raised more than $3.6 million to combat cancer.
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.